Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 84 articles: HTML format Text format

Single Articles

February 2012
1. ZHU H , Wong-Staal F, Lee H, Syder A, et al
   Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals.
   J Infect Dis. 2012;205:656-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. DELWART E , Slikas E, Stramer SL, Kamel H, et al
   Genetic Diversity of Recently Acquired and Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections in US Blood Donors.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. RAGHURAMAN S , Park H, Osburn WO, Winkelstein E, et al
   Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SU WJ , Liu CC, Liu DP, Chen SF, et al
   Effect of Age on the Incidence of Acute Hepatitis B After 25 Years of a Universal Newborn Hepatitis B Immunization Program in Taiwan.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SCHWARZ KB
   More Lessons From the Taiwanese Hepatitis B Virus Vaccine Program.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
6. NAGGIE S , Rallon NI, Benito JM, Morello J, et al
   Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PETERS PJ , Marston BJ
   Preventing Deaths in Persons With HIV/Hepatitis B Virus Coinfection: A Call to Accelerate Prevention and Treatment Efforts.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. CHUN HM , Roediger MP, Hullsiek KH, Thio CL, et al
   Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
9. OCHI H , Hayes CN, Abe H, Hayashida Y, et al
   Toward the Establishment of a Prediction System for the Personalized Treatment of Chronic Hepatitis C.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LAU GK , Wang FS
    Management of Chronic Hepatitis B e Antigen-Negative Disease: Another Step Forward.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. TSENG TC , Liu CJ, Chen CL, Wang CC, et al
    Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
12. SHEBL FM , Pfeiffer RM, Buckett D, Muchmore B, et al
    IL28B rs12979860 Genotype and Spontaneous Clearance of Hepatitis C Virus in a Multi-Ethnic Cohort of Injection Drug Users: Evidence for a Supra-Additive Association.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. HAGAN H
    Agent, Host, and Environment: Hepatitis C Virus in People Who Inject Drugs.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
14. THIBAULT V , Bara JL, Nefau T, Duplessy-Garson C, et al
    Hepatitis C Transmission in Injection Drug Users: Could Swabs Be the Main Culprit?
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. DOERRBECKER J , Friesland M, Ciesek S, Erichsen TJ, et al
    Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MEUNIER JC , Bukh J, Diaz G, Tovo PA, et al
    Neutralizing Antibodies to Hepatitis C Virus in Perinatally Infected Children Followed Up Prospectively.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CHATTERGOON MA , Levine JS, Latanich R, Osburn WO, et al
    High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. INOUE J , Ueno Y, Wakui Y, Fukushima K, et al
    Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients.
    J Infect Dis. 2011;204:1017-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MEUNIER JC , Gottwein JM, Houghton M, Russell RS, et al
    Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.
    J Infect Dis. 2011;204:1186-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KATSOUNAS A , Trippler M, Kottilil S, Lempicki RA, et al
    Altered Expression of SHIP, a Toll-like Receptor Pathway Inhibitor, Is Associated With the Severity of Liver Fibrosis in Chronic Hepatitis C Virus Infection.
    J Infect Dis. 2011;204:1181-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SATOH M , Saito M, Takano T, Kasama Y, et al
    Monoclonal Antibody 2-152a Suppresses Hepatitis C Virus Infection Through Betaine/GABA Transporter-1.
    J Infect Dis. 2011;204:1172-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. KURBANOV F , Abdel-Hamid M, Latanich R, Astemborski J, et al
    Genetic Polymorphism in IL28B Is Associated With Spontaneous Clearance of Hepatitis C Virus Genotype 4 Infection in an Egyptian Cohort.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. VERSTREPEN BE , Depla E, Rollier CS, Mares G, et al
    Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced e1-neutralizing antibodies.
    J Infect Dis. 2011;204:837-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ZEREMSKI M , Dimova R, Astemborski J, Thomas DL, et al
    CXCL9 and CXCL10 Chemokines as Predictors of Liver Fibrosis in a Cohort of Primarily African-American Injection Drug Users With Chronic Hepatitis C.
    J Infect Dis. 2011;204:832-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SMITH BD , Drobeniuc J, Jewett A, Branson BM, et al
    Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus.
    J Infect Dis. 2011;204:825-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. TAMURA R , Kanda T, Imazeki F, Wu S, et al
    Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4.
    J Infect Dis. 2011;204:793-801.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
27. SCOTT J , Holte S, Urban T, Burgess C, et al
    IL28B Genotype Effects During Early Treatment with Peginterferon and Ribavirin in Difficult-to-Treat Hepatitis C Virus Infection.
    J Infect Dis. 2011;204:419-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ZOUTENDIJK R , Hansen BE, van Vuuren AJ, Boucher CA, et al
    Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss.
    J Infect Dis. 2011;204:415-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LIK-YUEN CHAN H , Lai-Hung Wong G, Tse CH, Chan HY, et al
    Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients.
    J Infect Dis. 2011;204:408-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ITALIANO CM , Speers DJ, Chidlow GR, Dowse GK, et al
    Hepatitis B Outbreak Following a Mass-casualty Incident, Australia.
    J Infect Dis. 2011;204:400-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. WARD JW , Averhoff F
    Refugees, mass casualties, and hepatitis B transmission.
    J Infect Dis. 2011;204:338-9.
    PubMed     Text format     Related articles   
    
    
    
    
32. PENG LF , Schaefer EA, Maloof N, Skaff A, et al
    Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme a synthase.
    J Infect Dis. 2011;204:609-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. FORESTIER N , Larrey D, Marcellin P, Guyader D, et al
    Antiviral Activity of Danoprevir (ITMN-191/RG7227) in Combination With Pegylated Interferon {alpha}-2a and Ribavirin in Patients With Hepatitis C.
    J Infect Dis. 2011;204:601-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MORRILL JC , Peters CJ
    Mucosal Immunization of Rhesus Macaques With Rift Valley Fever MP-12 Vaccine.
    J Infect Dis. 2011;204:617-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
35. STAMATAKI Z , Coates S, Abrignani S, Houghton M, et al
    Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
36. CHAYAMA K , Hayes CN, Abe H, Miki D, et al
    IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C.
    J Infect Dis. 2011;204:84-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. HAGAN H , Pouget ER, Des Jarlais DC
    A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.
    J Infect Dis. 2011;204:74-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. TSUGE M , Takahashi S, Hiraga N, Fujimoto Y, et al
    Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.
    J Infect Dis. 2011;204:224-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. MORRILL JC , Peters CJ
    Protection of MP-12-Vaccinated Rhesus Macaques Against Parenteral and Aerosol Challenge With Virulent Rift Valley Fever Virus.
    J Infect Dis. 2011;204:229-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
40. CRUM-CIANFLONE NF , Wilkins K, Lee AW, Grosso A, et al
    Long-term Durability of Immune Responses After Hepatitis A Vaccination Among HIV-Infected Adults.
    J Infect Dis. 2011;203:1815-1823.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KUNIHOLM MH , Gao X, Xue X, Kovacs A, et al
    The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2011;203:1807-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. REIBERGER T , Payer BA, Kosi L, Heil PM, et al
    Concomitant Highly Active Antiretroviral Therapy Leads to Smaller Decline and Faster Recovery of CD4+ Cell Counts During and After Pegylated Interferon Plus Ribavirin Therapy in HIV-Hepatitis C Virus Coinfected Patients.
    J Infect Dis. 2011;203:1802-1806.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BANDYOPADHYAY S , Friedman RC, Marquez RT, Keck K, et al
    Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture.
    J Infect Dis. 2011;203:1753-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. LINDH M , Lagging M, Farkkila M, Langeland N, et al
    Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus.
    J Infect Dis. 2011;203:1748-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. BARREIRO P , Pineda JA, Rallon N, Naggie S, et al
    Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients Receiving Antiretroviral Therapy.
    J Infect Dis. 2011;203:1629-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
46. KANG J , Blalock GR, Dimitrov JD
    Thermodynamic Analysis of Hepatitis C Virus Vitality in Syringes.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
47. COLSON P , Gerolami R
    Two Years' Persistence of Naturally Present Substitution R155K Within Hepatitis C Virus NS3 Protease in the Absence of Protease Inhibitor-based Therapy.
    J Infect Dis. 2011;203:1341-2.
    PubMed     Text format     Related articles   
    
    
    
    
48. SIMMONS R , Sharp C, Sims S, Kloverpris H, et al
    High Frequency, Sustained T Cell Responses to PARV4 Suggest Viral Persistence In Vivo.
    J Infect Dis. 2011;203:1378-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
49. AN P , Winkler C, Guan L, O'Brien SJ, et al
    A Common HLA-DPA1 Variant is a Major Determinant of Hepatitis B Virus Clearance in Han Chinese.
    J Infect Dis. 2011;203:943-947.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
50. YONEDA S , Umemura T, Katsuyama Y, Kamijo A, et al
    Association of Serum Cytokine Levels with Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. GREBELY J , Dore GJ
    Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.
    J Infect Dis. 2011;203:571-4.
    PubMed     Text format     Related articles   
    
    
    
    
52. THURAIRAJAH PH , Hegazy D, Demaine A, Kaminski ER, et al
    Loss of Virus-specific T-Cell Responses in HCV Exposed Uninfected Injection Drug Users With Drug Rehabilitation.
    J Infect Dis. 2011;203:847-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. NDERITU L , Lee JS, Omolo J, Omulo S, et al
    Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus.
    J Infect Dis. 2011;203:655-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. MEHTA SH , Astemborski J, Kirk GD, Strathdee SA, et al
    Changes in Blood-borne Infection Risk Among Injection Drug Users.
    J Infect Dis. 2011;203:587-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
55. DE VRIES-SLUIJS TE , Hansen BE, van Doornum GJ, Kauffmann RH, et al
    A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive Patients.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. NATTERMANN J , Vogel M, Nischalke HD, Danta M, et al
    Genetic Variation in IL28B and Treatment-Induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. HASHEM M , El-Karaksy H, Shata MT, Sobhy M, et al
    Strong Hepatitis C Virus (HCV)-specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. YEUNG P , Wong DK, Lai CL, Fung J, et al
    Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. YONKERS NL , Sieg S, Rodriguez B, Anthony DD, et al
    Reduced Naive CD4 T Cell Numbers and Impaired Induction of CD27 in Response to T Cell Receptor Stimulation Reflect a State of Immune Activation in Chronic Hepatitis C Virus Infection.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BABIK JM , Cohan D, Monto A, Hartigan-O'Connor DJ, et al
    The human fetal immune response to hepatitis C virus exposure in utero.
    J Infect Dis. 2011;203:196-206.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
61. LE POGAM S , Seshaadri A, Ewing A, Kang H, et al
    RG7128 Alone or in Combination with Pegylated Interferon-alpha2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected Patients.
    J Infect Dis. 2010;202:1510-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. IRVING WL , Brown RJ
    Acute Hepatitis C Virus Infection: A Dynamic-and Challenging-Concept.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
63. SMITH JA , Aberle JH, Fleming VM, Ferenci P, et al
    Dynamic Coinfection with Multiple Viral Subtypes in Acute Hepatitis C.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MARTIN MP , Qi Y, Goedert JJ, Hussain SK, et al
    IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. MANSOUR H , Laird ME, Saleh R, Casrouge A, et al
    Circulating Plasmacytoid Dendritic Cells in Acutely Infected Patients with Hepatitis C Virus Genotype 4 Are Normal in Number and Phenotype.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. HWANG LX , Grimes CX, Tran TX, Clark A, et al
    Accelerated Hepatitis B Vaccination Schedule among Drug Users: A Randomized Controlled Trial.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BARNES E , Flanagan P, Brown A, Robinson N, et al
    Failure to Detect Xenotropic Murine Leukemia Virus–Related Virus in Blood of Individuals at High Risk of Blood‐Borne Viral Infections.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
68. RIBEIRO RX , Germanidis G, Powers KX, Pellegrin B, et al
    Hepatitis B Virus Kinetics under Antiviral Therapy Sheds Light on Differences in Hepatitis B e Antigen Positive and Negative Infections.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. EICK A , Ticehurst J, Tobler S, Nevin R, et al
    Hepatitis E Seroprevalence and Seroconversion among US Military Service Members Deployed to Afghanistan.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. LABRIQUE AB , Nelson KE
    Hepatitis E Virus Infections among US Military Personnel Deployed to Afghanistan.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
71. MORELLO J , Cuenca L, Soriano V, Medrano J, et al
    Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon-Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
72. RICH JD , Taylor LE
    The Beginning of a New Era in Understanding Hepatitis C Virus Prevention.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
73. PAINTSIL E , He H, Peters C, Lindenbach BD, et al
    Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. GYARMATHY VA
    Receptive syringe sharing and infection risk: to clean or not to clean.
    J Infect Dis. 2010;202:499.
    PubMed     Text format     Related articles   
    
    
    
    
75. HOLMBERG SD , Ward JW
    Hepatitis Delta: Seek and Ye Shall Find.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
76. KUCIRKA LM , Farzadegan H, Feld JJ, Mehta SH, et al
    Prevalence, Correlates, and Viral Dynamics of Hepatitis Delta among Injection Drug Users.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. LEGRAND-ABRAVANEL F , Kamar N, Sandres-Saune K, Garrouste C, et al
    Characteristics of Autochthonous Hepatitis E Virus Infection in Solid-Organ Transplant Recipients in France.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. COLSON P , Borentain P, Queyriaux B, Kaba M, et al
    Pig Liver Sausage as a Source of Hepatitis E Virus Transmission to Humans.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. PURCELL RH , Emerson SU
    Hidden Danger: The Raw Facts about Hepatitis E Virus.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
80. BURBELO PD , Kovacs JA, Ching KH, Issa AT, et al
    Proteome-wide Anti-Hepatitis C Virus (HCV) and Anti-HIV Antibody Profiling for Predicting and Monitoring the Response to HCV Therapy in HIV-Coinfected Patients.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. RAY R , Meyer K, Banerjee A, Basu A, et al
    Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. CHARY A , Winters MA, Kottilil S, Murphy AA, et al
    Impact of Interferon-Ribavirin Treatment on Hepatitis C Virus (HCV) Protease Quasispecies Diversity in HIV- and HCV-Coinfected Patients.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
83. CHUNG H , Watanabe T, Kudo M, Chiba T, et al
    Hepatitis C Virus Core Protein Induces Homotolerance and Cross-Tolerance to Toll-Like Receptor Ligands by Activation of Toll-Like Receptor 2.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KAUR P , Paliwal A, Durantel D, Hainaut P, et al
    DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: